CanariaBio reaches 50% target enrolment for Phase III clinical study of oregovomab to treat front-line advanced ovarian cancer

EVERSANA collaborates with Accord BioPharma to support launch of CAMCEVI (leuprolide) 42mg injection emulsion

Ascentage Pharma's APG-5918 receives approval from FDA for first-in-human study

Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen

Lynparza Receives Positive Opinion from EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer

US FDA Approves Prestige Biopharma's IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510

Bayer opens new research centre in Boston-Cambridge

BioLineRx signs collaboration agreement with GenFleet Therapeutics

IDEAYA Biosciences selects potential first-in-class Pol Theta Helicase development candidate

US FDA Places Partial Clinical Hold On Nuvation Bio Phase 1 Study of NUV-422 in Solid Tumors

Sling Therapeutics names new chairman of the board of directors

AstraZeneca reports Lynparza recommended in EU for early breast cancer

Antengene enters into clinical trial collaboration with BeiGene

AIkido Pharma establishes wholly owned financial services subsidiary

AbbVie announces quarterly cash dividend